MedPath

microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer

Conditions
Prostate Carcinosarcoma
Interventions
Biological: High PSA levels
Registration Number
NCT02964351
Lead Sponsor
Assuta Medical Center
Brief Summary

In our study, the investigators want to find correlation between circulating miRNAs associated with prostate cancer metastases to bones and to lymph nodes separately with results of 68Ga-PSMA ligand PET (positron emission computed) imaging.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
120
Inclusion Criteria
  • Proven Adeno-carcinoma
  • Underwent prostatectomy and still present high PSA levels
  • Refered to PSMA exam.
Exclusion Criteria
  • Below 18 years old
  • HIV/HBV (hepatitis B virus)/HCV (hepatitis C virus) positive
  • Additional malignancy during the past five years.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
High PSA (prostate-specific antigen) levelsHigh PSA levels-
Primary Outcome Measures
NameTimeMethod
Metastasis size and location18 months

Location of metastasis by a report analyzing the pathological examination (PET-MR output).

Secondary Outcome Measures
NameTimeMethod
MicroRNA profile by using Nano-string technology validated by real time PCR24 months

Validation of MicroRNA pattern by using real time PCR

© Copyright 2025. All Rights Reserved by MedPath